These changes influence the transcription factor One Cut Homeobox 2, which ultimately affects the expression of stemness-related genes like NANOG, OCT4, and SOX2, contributing to the increased adaptiveness of cancer cells against therapies. This evidence concerns the gene SOX2 and cancer.